Compare Davita Inc (DVA) vs McDonald's Corp (MCD) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Davita Inc vs McDonald's Corp — how do they compare? Davita Inc trades at $178.35 (market cap $11.72B), while McDonald's Corp trades at $273.72 (market cap $193.70B). The key difference: McDonald's Corp is far larger — about 16.5× Davita Inc's market cap, and McDonald's Corp pays a 2.72% dividend while Davita Inc pays none. Which is the better fit depends on your goals.
| DVA | MCD | |
|---|---|---|
Market Cap | $11.72B | $193.70B |
Sector | Health | Consumer Cyclical |
52-Week High | $240.96 | $341.06 |
52-Week Low | $103.87 | $262.80 |
Enterprise Value | $24.44B | $247.47B |
Volume | — | 2,230,036 |
Dividend Yield | — | 2.72% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
DaVita (DVA) trades at $183.77, up 1.72% today, with a mixed technical picture showing bearish moving averages but bullish oscillators. The company reported strong Q2 2026 earnings of $4.02 per share, beating estimates, driven by volume growth. Revenue reached $13.64 billion in 2025, with a net income margin of 6.05%. Analyst consensus is a Buy with a $232.25 price target, though technical signals are bearish overall.
The outlook for DVA is cautiously optimistic, supported by earnings beats and volume growth, but risks include reimbursement pressure and high debt levels. The stock offers potential upside to the consensus target, yet investors face headwinds from margin compression and technical bearishness.
McDonald's (MCD) trades at $274.48, down 0.64% for the day, with a bullish technical signal from moving averages and neutral oscillators. The company reported consistent earnings beats in recent quarters, with Q3 2026 EPS expected at $3.41. Revenue grew to $26.89 billion in 2025, supported by a net income margin of 31.72%. Recent news highlights the launch of the 'McDonald's NEXT' strategy focusing on automation and customer experience improvements.
The outlook remains positive with a consensus price target of $322.45, implying significant upside. Strong fundamentals and analyst buy ratings (59.68%) support growth, though risks include inflationary pressures on franchisee margins and high long-term debt of $38.42 billion. The stock offers a solid dividend yield with recent payouts of $1.86 per share.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Davita Inc
DaVita is the largest provider of dialysis services in the United States, boasting market share that eclipses 35% when measured by both patients and clinics. The firm operates over 3,100 facilities worldwide, mostly in the U.S., and treats over 240,000 patients globally each year. Government payers dominate U.S. dialysis reimbursement. DaVita receives approximately 69% of U.S. sales at government (primarily Medicare) reimbursement rates, with the remaining 31% coming from commercial insurers. However, while commercial insurers represented only about 10% of the U.S. patients treated, they represent nearly all of the profits generated by DaVita in the U.S. dialysis business.
Read more on DVA →About McDonald's Corp
McDonald's Corporation franchises and operates fast-food restaurants in the global restaurant industry. The Company's restaurants serves a variety of value-priced menu products in countries around the world.
Read more on MCD →
